LOTTE Biologics Songdo Plant 1 Lands First Major Commercial Manufacturing Agreement Ahead of Launch
LOTTE Biologics Songdo Plant 1 has secured its first major commercial manufacturing agreement with a global pharmaceutical company ahead of its operational launch. The deal covers integrated drug substance and drug product manufacturing, with commercial production targeted for 2027.
